Javascript seems to be disabled. This will break some core site features. Please enable javascript or revisit this site from another device.
PROGRAM - click here for the program (PDF)
09.50-10.00 Welcome (Gustav Smith, Malin Levin)
10.00-10.30 State of the (he)art Lecture: Therapeutic paradigms in heart failure
Karl Swedberg, Gothenburg
10.30-11.50 Mechanistic insights into myocardial disease (John Pernow, Charlotta Ljungman)
Evaluation of human heart disease through animal models: opportunities and limitations – Henrik Isackson, Uppsala
Myocardial energetics and cardiomyocyte function - Malin Levin, Gothenburg
Myocardial stunning in ischemic heart failure – Björn Redfors, Gothenburg
Novel mechanisms that link systemic inflammation to myocardial disease – Daniel C. Andersson, Stockholm
11.50-12.40 Lunch
12.40-13.10 Genetics in myocardial disease (Christina Christersson)
Kristina Haugaa, Stockholm
13.10-14.10 Mechanistic insights into valvular disease (Odd Bech-Hanssen, Henrik Isackson)
Linking vascular, myocardial and valvular disease - Karl-Henrik Grinnemo, Uppsala
Lipids and inflammation in calcific aortic valve disease - Magnus Bäck, Stockholm
Linking hemostasis with valvular calcifications - Christina Christersson, Uppsala
14.10-15.10 Functional imaging (Isabel Goncalves, Henrik Engblom)
Computed tomography Imaging – Erika Fagman, Gothenburg
Cardiac magnetic resonance imaging – Marcus Carlsson, Stockholm
Nuclear cardiology – Elin Trädgårdh, Malmö
15.10-15.40 Coffee
15.40-16.40 Established and emerging biomarkers (Bruna Gigante, Entela Bollano)
Circulating biomarkers for heart failure – Krister Lindmark, Stockholm
Circulating biomarkers in valvular disease - Stefan Söderberg, Umeå
Genetic contribution to aortic valve disease and associated aortopathy – Hanna Björk, Stockholm
16.40-17.00 Future opportunities in valvular and myocardial disease treatment (Martin Magnusson)
Gustav Smith, Gothenburg/Lund